A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis: Single Centre, Phase 2 Trial

Trial Profile

A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis: Single Centre, Phase 2 Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2012

At a glance

  • Drugs Lamotrigine (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Apr 2010 Results were presented at the 62nd Annual Meeting of the American Academy of Neurology.
    • 09 Sep 2009 Results have been presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
    • 12 Feb 2009 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top